Experimental study demonstrates that optimal hydraulic retention time depends on coagulant mechanism in tube flocculators, highlighting pathways for sustainable decentralized water treatment.
Access to safe drinking water remains a global challenge, particularly in decentralized and low-resource settings where conventional treatment technologies may be economically or operationally impractical. Combining low-energy hydraulic flocculation systems with biodegradable natural coagulants represents a promising strategy for sustainable water treatment. This study investigated the influence of hydraulic retention time (HRT) on the clarification performance of aluminum sulfate, Moringa oleifera, and Aloe vera in continuous-flow helically coiled tube flocculators (HCTFs). Four HRTs (1.71–6.84 min) were obtained by varying reactor length while maintaining a constant flow rate of 0.5 L/min. Synthetic water with an initial turbidity of approximately 100 NTU was treated, and clarification performance was evaluated by residual turbidity and turbidity removal efficiency. Two-way ANOVA revealed significant effects of HRT and coagulant type, as well as a significant interaction between these factors (p < 0.001), indicating that the influence of HRT depended on the dominant coagulation mechanism. Aluminum sulfate maintained consistently high turbidity removal efficiencies (96.3–98.1%) regardless of HRT. In contrast, Moringa oleifera achieved the highest clarification efficiency (99.5%) and a final turbidity of 0.49 NTU at the longest HRT, whereas Aloe vera exhibited the greatest hydraulic sensitivity, with turbidity removal increasing from 78.9% to 96.1% as HRT increased. The results demonstrate that HRT should be selected according to the dominant coagulation mechanism of the coagulant rather than adopted as a fixed design parameter. This mechanism-based approach provides a rational basis for designing and optimizing continuous-flow flocculators and supports the development of compact, efficient, and sustainable decentralized water treatment systems.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: